- CA$138.98m
- CA$125.26m
- $65.49m
- 73
- 46
- 71
- 68
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10.3 | 12.7 | 13 | 15.9 | 65.5 |
Cost of Revenue | |||||
Gross Profit | 6.67 | 9.84 | 10.3 | 12.7 | 58.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 15.6 | 14.3 | 52.1 | 11.2 | 22.1 |
Operating Profit | -5.31 | -1.63 | -39.1 | 4.71 | 43.4 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -9.55 | -8.48 | -41.9 | 3.76 | 41.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -9.36 | -8.8 | -38.5 | -3.99 | 12.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2.44 | -8.8 | -38.5 | -3.99 | 12.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.44 | -8.8 | -38.5 | -3.99 | 12.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.211 | -0.129 | -0.011 | -0.031 | 0.11 |
Special Dividends per Share |